Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Tuesday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of AMPE opened at $0.10 on Tuesday. Ampio Pharmaceuticals has a 52-week low of $0.07 and a 52-week high of $8.30. The stock has a 50 day moving average price of $0.20 and a 200 day moving average price of $1.06. The company has a market capitalization of $114,000.00, a price-to-earnings ratio of -0.01 and a beta of 2.20.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.